Teprotumumab for treating thyroid eye disease [ID6432]

Draft guidance: 1

Committee papers (PDF 8.5 MB)

Public committee slides (PowerPoint 772 KB)

Draft consultation document (downloadable version) (PDF 274 KB)

Draft consultation document (online commenting)

Final scope (PDF 136 KB)

Final stakeholder list (PDF 131 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 385 KB)

Draft scope post referral (PDF 215 KB)